The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
Open accessAbstract
BACKGROUND AND AIMS: An evaluation is made of the utility of fecal calprotectin in predicting relapse in patients with inflammatory bowel disease (IBD). The possible differences in its predictive capacity in Crohn's disease (CD) versus ulcerative colitis (UC), and the different phenotypes, are also examined. METHODS: This is a prospective study with 135 patients diagnosed with IBD in clinical remission for at least 3 months. The patients submitted a stool sample within 24 hours after the baseline visit, for the measurement of fecal calprotectin. All patients were followed-up on for one year. RESULTS: Sixty-six patients had CD and 69 UC. Thirty-nine (30%) suffered from relapse. The fecal calprotectin concentration was higher among the patients with relapse than in those that remained in remission: 444 µg/g (95% CI 34-983) versus 112 µg/g (95% CI 22-996); p<0.01. Patients with CD and calprotectin>200 µg/g relapsed 4 times more often than those with lower marker concentrations. In UC, calprotectin>120 µg/g was associated with a 6-fold increase in the probability of disease activity outbreak. The predictive value was similar in UC and CD with colon involvement and inflammatory pattern. In this group, calprotectin>120 µg/g predicted relapse risk with a sensitivity of 80% and a specificity of 60%. Relapse predictive capacity was lower in patients with ileal disease. CONCLUSIONS: Fecal calprotectin may be a useful marker for predicting relapse in patients with IBD. Its predictive value is greater in UC and CD with colon involvement and inflammatory pattern, compared with ileal CD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0359 · Cited by 149
Cited by
Turner, D., Ruemmele, F. M., Orlanski‐Meyer, E., Griffiths, A. M., de Carpi, J. M., Bronsky, J., Veres, G., Aloi, M., Strisciuglio, C., Braegger, C. P., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002035 · Cited by 481
Biomarkers of Inflammation in Inflammatory Bowel Disease
Sands, B. E. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.003 · Cited by 405
Mao, R., Xiao, Y.-L., Gao, X., Chen, B.-L., He, Y., Yang, L., Hu, P.-J., & Chen, M.-H. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22861 · Cited by 280
Ingestible electronics for diagnostics and therapy
Steiger, C., Abramson, A., Nadeau, P., Chandrakasan, A. P., Langer, R., & Traverso, G. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0070-3 · Cited by 274
Metadata
- Authors
- García-Sánchez, V., Iglesias-Flores, E., González, R., Gisbert, J. P., Gallardo-Valverde, J. M., González-Galilea, Á., Naranjo-Rodríguez, A., de Dios-Vega, J. F., Muntané, J., & Gómez-Camacho, F.
- Venue
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-06
- Volume
- 4
- Issue
- 2
- Pages
- 144-152
- ISSN
- 1873-9946 (ISSN-L)
- OpenAlex
- W2032206624
- Cited by
- 163
- References
- 1
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? https://app.cochat.ai/papers/10.1016/j.crohns.2009.09.008
- The paper
- García-Sánchez, V., Iglesias-Flores, E., González, R., Gisbert, J. P., Gallardo-Valverde, J. M., González-Galilea, Á., Naranjo-Rodríguez, A., de Dios-Vega, J. F., Muntané, J., & Gómez-Camacho, F. (2010). Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? Journal of Crohn's and Colitis. https://doi.org/10.1016/j.crohns.2009.09.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.